Azeria Therapeutics competitorsClear all
Azeria Therapeutics's top competitors include Calidi Biotherapeutics and Immutep.
 Azeria Therapeutics Azeria Therapeutics is a company that develops a cancer drug intended to aid in the treatment of breast and prostate cancer patients. |  Calidi Biotherapeutics Calidi Biotherapeutics is a company that specializes in oncolytic virus-based immunotherapies for cancer. |  Immutep Immutep (formerly Prima BioMed) is a biotechnology company focused on developing autoimmune and cancer immunotherapy treatment. | |
Founding Date | Founding Date 2017 | Founding Date 2014 | Founding Date 2001 |
Type | Type Private | Type Private | Type Public |
Tags | |||
Locations | Locations Cambridge, GB HQ | Locations San Diego, US HQ | Locations Sydney, AU HQ Sydney, AU The Rocks, AU Orsay, FR Berlin, DE Leipzig, DE |
Employees | Employees 3 | Employees 26 | Employees 2427% decrease |
Funding | |||
Latest funding round | Latest funding round $ 41.3m (over 2 years ago) | Latest funding round $ 8.2m (over 2 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 46.5m | Total funding raised $ 20m | Total funding raised N/A |
For sources of this data, please see the company profile
View company profiles
Calidi Biotherapeutics
HQ
San Diego, US
Employees
26
Calidi Biotherapeutics is a company that specializes in oncolytic virus-based immunotherapies for cancer.
View companyImmutep
HQ
Sydney, AU
Employees
24↓ 27% decrease
Immutep (formerly Prima BioMed) is a biotechnology company focused on developing autoimmune and cancer immunotherapy treatment.
View company